CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
Subscribe To Our Newsletter & Stay Updated